Supplements and Social Skills Intervention Study
Launched by NATIONAL HEALTHCARE GROUP, SINGAPORE · Jan 8, 2009
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
Serious adult crime and violence is a social problem despite decades of intervention and prevention work. One of the reasons for the world-wide failure to prevent this problem stems from (a) a failure to tackle the biological component of the crime/ violence equation in treatment programs, and (b) the failure to tackle this adult condition in its formative childhood origins. Investing modest resources in early biosocial prevention programs could yield enormous long-term financial dividends in terms of the saved legal, medical, social, and psychological costs resulting from adult crime. This...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects between ages 7 and 16 years
- • Subjects who fulfils all criteria for a DSM-IV diagnosis of ADHD, conduct disorder, or oppositional defiant disorder
- • Subjects with willingness to participate in a randomized, double-blind controlled trial,
- • Subjects with complete with written, informed parental consent and assent
- • Subjects with IQ of 70 or more
- Exclusion Criteria:
- • Subjects who have IQ in the below 70
- • Subjects who are younger than 7 years old
- • Those without written parental consent will not be allowed to participate in the study
- • Those with brain pathology such as serious head injury, epilepsy will be excluded
About National Healthcare Group, Singapore
The National Healthcare Group (NHG) in Singapore is a leading integrated healthcare provider committed to delivering high-quality, patient-centered care through its extensive network of hospitals, polyclinics, and specialty care services. As a prominent sponsor of clinical trials, NHG is dedicated to advancing medical research and innovation, fostering collaboration between healthcare professionals and researchers to enhance treatment options and improve health outcomes. The organization emphasizes rigorous ethical standards and scientific integrity, ensuring that all trials contribute valuable insights to the global medical community while prioritizing patient safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Daniel SS Fung, A/Prof
Principal Investigator
Institute of Mental Health, Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials